EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies

Chenbin Bian, Zhuangzhuang Zheng, Jing Su, Sitong Chang, Huiyuan Yu, Jindian Bao, Ying Xin, Xin Jiang

Frontiers in Pharmacology · 12.09.2023 · 14

DOI: 10.3389/fphar.2023.1271613 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 12.09.2023. Verfasst von Chenbin Bian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jilin Provincial Key Laboratory of Radiation Oncology and Therapy, The First Hospital of Jilin University, Changchun, China. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Copper is an indispensable micronutrient for the development and replication of all eukaryotes, and its redox properties are both harmful and beneficial to cells. An imbalance in copper homeostasis is thought to be involved in carcinogenesis. Importantly, cancer cell proliferation, angiogenesis, and metastasis cannot be separated from the effects of copper. Cuproposis is a copper-dependent form of cell death that differs from other existing modalities of regulatory cell death. The role of cuproptosis in the pathogenesis of the nervous and cardiovascular systems has been widely studied; however, its impact on malignant tumors is yet to be fully understood from a clinical perspective. Exploring signaling pathways related to cuproptosis will undoubtedly provide a new perspective for the development of anti-tumor drugs in the future. Here, we systematically review the systemic and cellular metabolic processes of copper and the regulatory mechanisms of cuproptosis in cancer. In addition, we discuss the possibility of targeting copper ion drugs to prolong the survival of cancer patients, with an emphasis on the most representative copper ionophores and chelators. We suggest that attention should be paid to the potential value of copper in the treatment of specific cancers.

Schlagwörter

Stichwörter der Autor:innen

cancer therapeuticscarcinogenesiscopper homeostasiscuproptosisdrug

Autor:innen und Institutionen

  • Jilin Provincial Key Laboratory of Radiation Oncology and Therapy, The First Hospital of Jilin University, Changchun, China.
  • Department of Radiation Oncology, The First Hospital of Jilin University, Changchun, China.
  • NHC Key Laboratory of Radiobiology, School of Public Health of Jilin University, Changchun, China.
  • Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, China.

Zitieren

APA

Bian, C., Zheng, Z., Su, J., Chang, S., Yu, H., Bao, J., Xin, Y., & Jiang, X. (2023). Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1271613

Vancouver

Bian C, Zheng Z, Su J, Chang S, Yu H, Bao J, et al. Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1271613

BibTeX
@article{Bian2023,
  author = {Bian, Chenbin and Zheng, Zhuangzhuang and Su, Jing and Chang, Sitong and Yu, Huiyuan and Bao, Jindian and Xin, Ying and Jiang, Xin},
  title = {Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1271613}
}
Kostenlos starten →